HK1012006A1 - Interaction trap systems for detecting protein interactions - Google Patents
Interaction trap systems for detecting protein interactionsInfo
- Publication number
- HK1012006A1 HK1012006A1 HK98113236A HK98113236A HK1012006A1 HK 1012006 A1 HK1012006 A1 HK 1012006A1 HK 98113236 A HK98113236 A HK 98113236A HK 98113236 A HK98113236 A HK 98113236A HK 1012006 A1 HK1012006 A1 HK 1012006A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- protein
- binding
- interaction
- gene
- protein interactions
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0012—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7)
- C12N9/0036—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on NADH or NADPH (1.6)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
- C12N15/1055—Protein x Protein interaction, e.g. two hybrid selection
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6897—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids involving reporter genes operably linked to promoters
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/35—Fusion polypeptide containing a fusion for enhanced stability/folding during expression, e.g. fusions with chaperones or thioredoxin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
- C07K2319/71—Fusion polypeptide containing domain for protein-protein interaction containing domain for transcriptional activaation, e.g. VP16
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/80—Fusion polypeptide containing a DNA binding domain, e.g. Lacl or Tet-repressor
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Bioinformatics & Computational Biology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Analytical Chemistry (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Analysing Materials By The Use Of Radiation (AREA)
- Vehicle Body Suspensions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US27808294A | 1994-07-20 | 1994-07-20 | |
PCT/US1995/009307 WO1996002561A1 (en) | 1994-07-20 | 1995-07-20 | Interaction trap systems for detecting protein interactions |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1012006A1 true HK1012006A1 (en) | 1999-07-23 |
Family
ID=23063609
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK98113236A HK1012006A1 (en) | 1994-07-20 | 1998-12-11 | Interaction trap systems for detecting protein interactions |
Country Status (9)
Country | Link |
---|---|
US (3) | US6004746A (xx) |
EP (2) | EP1405911A1 (xx) |
JP (1) | JP4064452B2 (xx) |
AT (1) | ATE254136T1 (xx) |
DE (1) | DE69532127T2 (xx) |
DK (1) | DK0773952T3 (xx) |
ES (1) | ES2210306T3 (xx) |
HK (1) | HK1012006A1 (xx) |
WO (1) | WO1996002561A1 (xx) |
Families Citing this family (85)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6399296B1 (en) * | 1994-07-20 | 2002-06-04 | The General Hospital Corporation | Interaction trap systems for detecting protein interactions |
ATE254136T1 (de) * | 1994-07-20 | 2003-11-15 | Gen Hospital Corp | Interaktions-fullensysteme zum nachweis von protein-interaktionen |
AU716893B2 (en) | 1995-04-11 | 2000-03-09 | General Hospital Corporation, The | Reverse two-hybrid systems |
DE29724617U1 (de) * | 1996-04-26 | 2002-06-13 | Massachusetts Institute Of Technology, Cambridge, Mass. | Drei-Hybrid-Kit zur Molekülauswahl |
JP2000508923A (ja) * | 1996-04-26 | 2000-07-18 | マサチューセッツ・インスティテュート・オブ・テクノロジー | 3―ハイブリッド・スクリーニング・アッセイ |
US5776689A (en) * | 1996-07-19 | 1998-07-07 | The Regents Of The University Of California | Protein recruitment system |
US5807708A (en) * | 1996-07-30 | 1998-09-15 | Millennium Pharmaceuticals, Inc. | Conservin nucleic acid molecules and compositions |
US5846722A (en) * | 1996-10-16 | 1998-12-08 | Terrapin Technologies, Inc. | System to detect small molecule/peptide interaction |
WO1998046796A1 (en) * | 1997-04-11 | 1998-10-22 | The Regents Of The University Of California | A method of screening nucleotide sequences to identify disruptors or effectors of biological processes or pathways |
AU3587599A (en) * | 1997-11-28 | 1999-06-16 | Invitrogen Corporation | Single chain monoclonal antibody fusion reagents that regulate transcript ion in vivo |
EP1035207A1 (en) * | 1999-03-09 | 2000-09-13 | MultiGene Biotech GmbH | cDNA molecules of the members of gene family encoding human fatty acid desaturases and their use in diagnosis and therapy |
EP1171595A1 (en) | 1999-04-12 | 2002-01-16 | Agensys, Inc. | 13 transmembrane protein expressed in prostate cancer |
EP1792989A1 (en) | 1999-04-12 | 2007-06-06 | Agensys, Inc. | 13 Transmembrane protein expressed in prostate cancer |
US20060073150A1 (en) | 2001-09-06 | 2006-04-06 | Mary Faris | Nucleic acid and corresponding protein entitled STEAP-1 useful in treatment and detection of cancer |
EP1198586B1 (en) * | 1999-06-26 | 2010-03-03 | Odyssey Thera, Inc. | An in vivo library-versus-library selection of optimized protein-protein interactions |
PT1200590E (pt) | 1999-08-12 | 2009-03-24 | Agensys Inc | Antigénio transmembranar lectina tipo c expresso em cancro da próstata humano e utilizações do mesmo |
DK1220913T3 (da) | 1999-10-05 | 2009-03-16 | Agensys Inc | G-protein-koblet-receptor opreguleret i prostatacancer og anvendelser deraf |
US6893818B1 (en) | 1999-10-28 | 2005-05-17 | Agensys, Inc. | Gene upregulated in cancers of the prostate |
US20030211495A1 (en) * | 2000-03-08 | 2003-11-13 | Richard Hopkins | Reverse n-hybrid screening method |
CA2415923C (en) | 2000-07-12 | 2011-10-25 | Agensys, Inc. | Novel tumor antigen useful in diagnosis and therapy of bladder, ovary, lung and kidney cancers |
CA2420990C (en) | 2000-08-28 | 2010-08-17 | Agensys, Inc. | Nucleic acid and corresponding protein entitled 85p1b3 useful in treatment and detection of cancer |
CA2421751C (en) * | 2000-09-11 | 2014-02-11 | Donald W. Kufe | Muc1 extracellular domain and cancer treatment compositions and methods derived therefrom |
CA2425208C (en) | 2000-09-26 | 2013-04-09 | Duke University | Rna aptamers and methods for identifying the same |
EP1355666B1 (en) | 2000-12-22 | 2012-06-13 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Use of repulsive guidance molecule (RGM) and its modulators |
WO2002058450A2 (en) * | 2000-12-22 | 2002-08-01 | Dana-Faber Cancer Institute, Inc. | Regulation of cell growth by muc1 |
JP4343534B2 (ja) | 2001-03-02 | 2009-10-14 | ゲーペーツェー バイオテック アクチェンゲゼルシャフト | 3ハイブリッド・アッセイ・システム |
US6924358B2 (en) | 2001-03-05 | 2005-08-02 | Agensys, Inc. | 121P1F1: a tissue specific protein highly expressed in various cancers |
US7271240B2 (en) | 2001-03-14 | 2007-09-18 | Agensys, Inc. | 125P5C8: a tissue specific protein highly expressed in various cancers |
EP1573024A4 (en) | 2001-04-10 | 2007-08-29 | Agensys Inc | NUCLEIC ACIDS AND SUITABLE PROTEINS SUITABLE FOR THE TREATMENT AND EVIDENCE OF VARIOUS CANCER DISEASES |
US20030191073A1 (en) | 2001-11-07 | 2003-10-09 | Challita-Eid Pia M. | Nucleic acid and corresponding protein entitled 161P2F10B useful in treatment and detection of cancer |
CA2448567C (en) * | 2001-05-25 | 2014-05-20 | Duke University | Modulators of nucleic acid ligands |
US20040049024A1 (en) * | 2001-12-07 | 2004-03-11 | Geoff Clark | Compositions and methods related to the minn1 tumor suppressor gene and protein |
US20040086945A1 (en) * | 2002-06-03 | 2004-05-06 | The Procter & Gamble Company | Hairless protein-interacting partner complexes and methods thereto |
CA2542171C (en) * | 2002-06-26 | 2015-12-15 | Abbott Gmbh & Co. Kg | Modulators and modulation of the interaction between rgm and neogenin |
US20040081653A1 (en) | 2002-08-16 | 2004-04-29 | Raitano Arthur B. | Nucleic acids and corresponding proteins entitled 251P5G2 useful in treatment and detection of cancer |
US20060099713A1 (en) * | 2002-10-01 | 2006-05-11 | Buck Institute | Targeted-assisted iterative screening (tais):a novel screening format for large molecular repertoires |
CA2860151A1 (en) | 2003-02-10 | 2004-08-26 | Agensys, Inc. | Nucleic acid and corresponding protein named 158p1d7 useful in the treatment and detection of bladder and other cancers |
US20080090770A1 (en) * | 2003-04-11 | 2008-04-17 | Belmares Michael P | Modulation of Muc1 Mediated Signal Transduction |
SI1629088T1 (sl) | 2003-05-30 | 2012-08-31 | Agensys Inc | Antigen izvornih celic prostate (psca) in njegova podzaporedja |
GB0315248D0 (en) * | 2003-06-30 | 2003-08-06 | Hoffmann La Roche | HCV regulated protein expression |
US8129506B2 (en) | 2003-10-24 | 2012-03-06 | Genzyme Corporation | Modulation of the interaction of MUC1 with MUC1 ligands |
EP2053409A1 (en) | 2003-11-20 | 2009-04-29 | F. Hoffmann-La Roche Ag | Specific markers for metabolic syndrome |
WO2005082458A1 (en) * | 2004-02-23 | 2005-09-09 | Genzyme Corporation | Muc1 antagonist enhancement of death receptor ligand-induced apoptosis |
JP4718541B2 (ja) | 2004-04-22 | 2011-07-06 | リガド・バイオサイエンシーズ・インコーポレーテツド | 改良された凝固因子調節剤 |
JP4651663B2 (ja) | 2004-05-28 | 2011-03-16 | アジェンシス,インコーポレイテッド | Pscaタンパク質に結合する抗体および関連分子 |
US8034553B2 (en) | 2004-06-24 | 2011-10-11 | Kimberly-Clark Worldwide, Inc. | Biomarkers for wound healing |
WO2006105488A2 (en) | 2005-03-31 | 2006-10-05 | Agensys, Inc. | Antibodies and related molecules that bind to 161p2f10b proteins |
US8906864B2 (en) | 2005-09-30 | 2014-12-09 | AbbVie Deutschland GmbH & Co. KG | Binding domains of proteins of the repulsive guidance molecule (RGM) protein family and functional fragments thereof, and their use |
US9243243B2 (en) | 2006-08-31 | 2016-01-26 | Nexigen Gmbh | Means and methods for detecting protein-peptide interactions |
EP1927364A1 (en) | 2006-12-01 | 2008-06-04 | Ecole Normale Superieure De Lyon | Polypeptides having modulatory effects on cells |
WO2008097844A2 (en) * | 2007-02-02 | 2008-08-14 | Dana -Farber Cancer Institute, Inc. | Methods and compositions relating to the regulation of apoptosis by muc1 and bh3- containing proapoptotic proteins |
WO2008097840A2 (en) | 2007-02-02 | 2008-08-14 | Dana-Farber Cancer Institute, Inc. | Methods and compositions relating to the regulation of muc1 by hsf1 and stat3 |
EP2034020A1 (en) * | 2007-08-30 | 2009-03-11 | Procomcure Biotech GmbH | Method for manufacturing a modified peptide |
US8962803B2 (en) | 2008-02-29 | 2015-02-24 | AbbVie Deutschland GmbH & Co. KG | Antibodies against the RGM A protein and uses thereof |
EP2101173A1 (en) * | 2008-03-14 | 2009-09-16 | Vivalis | In vitro method to determine whether a drug candidate active against a target protein is active against a variant of said protein |
CN102027561A (zh) * | 2008-05-15 | 2011-04-20 | 皇家飞利浦电子股份有限公司 | 生成x射线束的方法和系统 |
CA2777927A1 (en) | 2009-10-22 | 2011-04-28 | Centre National De La Recherche Scientifique | Inhibitors of guanine exchange factors and their use as anticancer drugs |
BR112012013734A2 (pt) | 2009-12-08 | 2017-01-10 | Abbott Gmbh & Co Kg | anticorpos monoclonais contra a proteína rgm a para uso no tratamento da degeneração da camada de fibras nervosas da retina. |
WO2011083147A1 (en) | 2010-01-08 | 2011-07-14 | Cemm-Forschungsinstitut Für Molekulare Medizin Gmbh | Wave1 inhibition in the medical intervention of inflammatory diseases and/or infections caused by a pathogen |
US20130116304A1 (en) | 2010-04-19 | 2013-05-09 | Ernst R. Werner | Tmem195 encodes for tetrahydrobiopterin-dependent alkylglycerol monooxygenase activity |
HUE039611T2 (hu) | 2012-01-27 | 2019-01-28 | Abbvie Deutschland | Készítmények és eljárások axondegenerációval járó betegségek diagnózisára és kezelésére |
US10208125B2 (en) | 2013-07-15 | 2019-02-19 | University of Pittsburgh—of the Commonwealth System of Higher Education | Anti-mucin 1 binding agents and uses thereof |
IL286025B2 (en) | 2014-12-24 | 2023-11-01 | Neximmune Inc | Nanoparticle preparations and immunotherapy methods |
EP3371311B1 (en) | 2015-11-06 | 2021-07-21 | Orionis Biosciences BV | Bi-functional chimeric proteins and uses thereof |
SG10202004259PA (en) | 2015-11-19 | 2020-06-29 | Asclepix Therapeutics Llc | Peptides with anti-angiogenic, anti-lymphangiogenic, and anti-edemic properties and nanoparticle formulations |
JP7030704B2 (ja) | 2016-02-05 | 2022-03-08 | オリオニス バイオサイエンシズ ビーブイ | 二重特異性シグナル伝達物質およびその使用 |
EP3426278B1 (en) | 2016-03-07 | 2024-01-03 | Vib Vzw | Cd20 binding single domain antibodies |
CA3023883A1 (en) | 2016-05-13 | 2017-11-16 | Orionis Biosciences Nv | Targeted mutant interferon-beta and uses thereof |
EP3455245A2 (en) | 2016-05-13 | 2019-03-20 | Orionis Biosciences NV | Therapeutic targeting of non-cellular structures |
US20190225670A1 (en) | 2016-10-04 | 2019-07-25 | Asclepix Therapeutics, Llc | Compounds and methods for activating tie2 signaling |
EP3529264B1 (en) | 2016-10-24 | 2022-03-09 | Orionis Biosciences BV | Targeted mutant interferon-gamma and uses thereof |
US11384154B2 (en) | 2017-02-06 | 2022-07-12 | Orionis Biosciences BV | Targeted chimeric proteins and uses thereof |
EP3576765A4 (en) | 2017-02-06 | 2020-12-02 | Orionis Biosciences, Inc. | TARGETED ENGINEERING INTERFERON AND USES OF IT |
CA3050601A1 (en) | 2017-02-07 | 2018-08-16 | Vib Vzm | Immune-cell targeted bispecific chimeric proteins and uses thereof |
WO2019028427A1 (en) | 2017-08-03 | 2019-02-07 | Asclepix Therapeutics, Llc. | METHODS OF IDENTIFYING AND PREPARING PHARMACEUTICAL AGENTS TO ACTIVATE TIE2 RECEPTOR |
US12059476B2 (en) | 2017-10-10 | 2024-08-13 | The Johns Hopkins University | Biodegradable biomimetic particles |
WO2019099678A1 (en) * | 2017-11-16 | 2019-05-23 | Synthex, Inc. | Selective modulation of protein-protein interactions |
KR20200128533A (ko) | 2018-02-05 | 2020-11-13 | 오리오니스 바이오사이언시즈 인코포레이티드 | 섬유아세포 결합제 및 이의 용도 |
SG11202108281UA (en) | 2019-02-15 | 2021-08-30 | Integral Molecular Inc | Claudin 6 antibodies and uses thereof |
CN113661175A (zh) | 2019-02-15 | 2021-11-16 | 整体分子公司 | 包含共同轻链的抗体及其用途 |
WO2020232343A1 (en) | 2019-05-15 | 2020-11-19 | Synthex, Inc. | Selective degradation of proteins |
GB202004514D0 (en) | 2020-03-27 | 2020-05-13 | Inst De Medicina Molecular Joaeo Lobo Antunes | Treatment of Immunosuppressive Cancer |
WO2024008755A1 (en) | 2022-07-04 | 2024-01-11 | Vib Vzw | Blood-cerebrospinal fluid barrier crossing antibodies |
WO2024077118A2 (en) | 2022-10-06 | 2024-04-11 | Bicara Therapeutics Inc. | Multispecific proteins and related methods |
WO2024118771A1 (en) | 2022-11-30 | 2024-06-06 | Integral Molecular, Inc. | Antibodies directed to claudin 6, including bispecific formats thereof |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4833080A (en) * | 1985-12-12 | 1989-05-23 | President And Fellows Of Harvard College | Regulation of eucaryotic gene expression |
US4980281A (en) * | 1988-02-10 | 1990-12-25 | Housey Gerard M | Method of screening for protein inhibitors and activators |
US5283173A (en) * | 1990-01-24 | 1994-02-01 | The Research Foundation Of State University Of New York | System to detect protein-protein interactions |
EP0496162A3 (en) * | 1990-12-24 | 1993-09-01 | Merck & Co. Inc. | Peptide inhibitors of ras-gap interaction |
US5270181A (en) * | 1991-02-06 | 1993-12-14 | Genetics Institute, Inc. | Peptide and protein fusions to thioredoxin and thioredoxin-like molecules |
US5885780A (en) * | 1991-07-19 | 1999-03-23 | University Of Utah | Method of obtaining small conformationally rigid conopeptides |
CA2054602C (en) * | 1991-10-31 | 2003-04-22 | Anthony Pawson | Method for assaying for a substance that affects an sh2-phosphorylated ligand regulatory system |
JP3537141B2 (ja) * | 1992-10-30 | 2004-06-14 | ザ ゼネラル ホスピタル コーポレーション | 新種蛋白質分離のための相互作用を用いる補捉システム |
US5695941A (en) * | 1994-06-22 | 1997-12-09 | The General Hospital Corporation | Interaction trap systems for analysis of protein networks |
ATE254136T1 (de) * | 1994-07-20 | 2003-11-15 | Gen Hospital Corp | Interaktions-fullensysteme zum nachweis von protein-interaktionen |
US6399296B1 (en) * | 1994-07-20 | 2002-06-04 | The General Hospital Corporation | Interaction trap systems for detecting protein interactions |
US6153380A (en) * | 1996-01-23 | 2000-11-28 | Rigel Pharmaceuticals, Inc. | Methods for screening for transdominant intracellular effector peptides and RNA molecules |
US6365344B1 (en) * | 1996-01-23 | 2002-04-02 | The Board Of Trustees Of The Leland Stanford Junior University | Methods for screening for transdominant effector peptides and RNA molecules |
US6114111A (en) * | 1998-03-30 | 2000-09-05 | Rigel Pharmaceuticals, Inc. | Mammalian protein interaction cloning system |
-
1995
- 1995-07-20 AT AT95928118T patent/ATE254136T1/de active
- 1995-07-20 ES ES95928118T patent/ES2210306T3/es not_active Expired - Lifetime
- 1995-07-20 EP EP03021647A patent/EP1405911A1/en not_active Withdrawn
- 1995-07-20 DE DE69532127T patent/DE69532127T2/de not_active Expired - Lifetime
- 1995-07-20 US US08/504,538 patent/US6004746A/en not_active Expired - Lifetime
- 1995-07-20 DK DK95928118T patent/DK0773952T3/da active
- 1995-07-20 JP JP50527796A patent/JP4064452B2/ja not_active Expired - Fee Related
- 1995-07-20 EP EP95928118A patent/EP0773952B1/en not_active Expired - Lifetime
- 1995-07-20 WO PCT/US1995/009307 patent/WO1996002561A1/en active IP Right Grant
-
1998
- 1998-12-11 HK HK98113236A patent/HK1012006A1/xx not_active IP Right Cessation
-
1999
- 1999-02-12 US US09/249,458 patent/US6242183B1/en not_active Expired - Lifetime
-
2008
- 2008-03-26 US US12/079,358 patent/US20090130676A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP0773952A4 (en) | 2000-01-19 |
JPH10504713A (ja) | 1998-05-12 |
DE69532127D1 (de) | 2003-12-18 |
WO1996002561A1 (en) | 1996-02-01 |
EP1405911A1 (en) | 2004-04-07 |
US6004746A (en) | 1999-12-21 |
ES2210306T3 (es) | 2004-07-01 |
DK0773952T3 (da) | 2004-03-22 |
US20090130676A1 (en) | 2009-05-21 |
US6242183B1 (en) | 2001-06-05 |
EP0773952A1 (en) | 1997-05-21 |
DE69532127T2 (de) | 2004-08-26 |
EP0773952B1 (en) | 2003-11-12 |
JP4064452B2 (ja) | 2008-03-19 |
ATE254136T1 (de) | 2003-11-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1012006A1 (en) | Interaction trap systems for detecting protein interactions | |
ATE316573T1 (de) | Wechselwirkendes fallensystem zur isolierung von proteinen | |
EP2290362A3 (en) | Synchronized analyte testing system | |
ATE253645T1 (de) | Verfahren zur bestimmung von säugetier nukleinsäuren aus stuhlproben und dafür benötigte reagenzien | |
EP0977035A3 (en) | A system for determining the electrical potential across a membrane | |
EP1965213A3 (en) | Microarrays and uses therefor | |
DE60118527D1 (de) | Sensible und multiplexe diagnostische tests zur proteinanalyse | |
DK0765389T3 (da) | Cellesystemer havende specifik interaktion på peptide bindingspar | |
SE9602545D0 (sv) | Broad specifivity affinity arrays: A qualitative appoach to complex sample discrimination | |
DE69715621D1 (de) | Drei hybriden screening test | |
WO1999058978A3 (en) | Tumour markers | |
NZ306051A (en) | Testing using electrochemiluminescence | |
ATE190728T1 (de) | Verfahren zur quantitativen bestimmung menschlichen akutphasen-serum-amyloid-a-proteins; rekombinantes protein; spezifischer antikörper | |
EP1403640A4 (en) | IMMOBILIZED PEPTIDE TRAY AND TARGET PROTEIN ANALYSIS METHOD USING THE SAME | |
WO1995014778A3 (en) | Dna sequence coding for a bmp receptor | |
AUPP660798A0 (en) | Method for measuring cellular adhesion | |
CA2213083A1 (en) | Detection of antibody production | |
WO2002050104A3 (en) | Methods and cells for detecting modulators of rgs proteins | |
ATE221579T1 (de) | Bestimmung von analyten unter verwendung zweier markierungen | |
JPS59141054A (ja) | 電気泳動装置 | |
WO2004061422A3 (en) | Bindingzyme arrays and high-throughput proteomic methods | |
EP1143011A3 (en) | A method of detecting biologically active substances | |
Durkee | Development of amplified detection systems for protein blotting using a solid phase coagulation assay. | |
WO2001084459A3 (de) | Verfahren zur ermittlung signifikanter knochendichteverluste | |
AU2003200189A1 (en) | Electrochemical Reporter System for Detecting Analytical Immunoassay and Molecular Biology Procedures |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PF | Patent in force | ||
PE | Patent expired |
Effective date: 20150719 |